High-value molecules going off-patent – from an emerging markets perspective
Emerging markets are much more heterogeneous place compared to regulated markets like the US and EU. Regulatory norms, application of [...]
Letter: Big Pharma should be treated as a public utility | Letters
Night after night I am bombarded with loud TV pitches for drugs whose names I can't pronounce, supposedly able to [...]
Add Amazon, Walmart Drug Discounts to Your Cost Comparison
This article was first published on NerdWallet.com . The sticker shock on some medicines can be staggering, especially without insurance. [...]
Opinion: To lower drug costs, define ‘cost’ to mean net cost after rebates
In what could be a turning point in the prescription drug debate, President Biden has made clear that the health [...]
Democrats’ Plans To Introduce Prescription Drug Pricing Reform Face Formidable Obstacles
For years, reducing prescription drug prices has been a policy goal of (mostly Democratic) legislators at the federal and state [...]
The Health 202: Senate Democrats eye vouchers to speed up potential new Medicare benefits
with Alexandra Ellerbeck Senate Democrats are exploring ways to send seniors vouchers worth hundreds of dollars to quickly afford hearing, [...]
South Korea’s preferential drug pricing system can boost innovation in pharma research, says GlobalData
South Korea has recently decided to provide practical support to innovative pharmaceutical companies by revising the existing health insurance benefits [...]
Specialty Drug Commercialization Process and Considerations
The specialty pharmacy drug pipeline is a rapidly growing segment of the pharmaceutical industry that primarily focuses on the development [...]
AWS for Health and OpenText for Healthcare – Better together
Earlier this month Amazon Web Services introduced AWS for Health , an offering of curated AWS services and AWS Partner [...]
Register Today for Upcoming World Congress Webinar Highlighting Four Common Value and Evidence Misconceptions
World Congress will host a webinar at 1:00 PM ET on September 21st, 2021. Consultant Pamela Divack will discuss common [...]
New Healthcare Podcast Series Features Harvard Doctor
Dr. Bapu Jena explores a different theme in each episode of the Freakonomics, M.D. podcast series. He uses his medical [...]
Open Text : Aws for Health and OpenText for Healthcare – Better together
Earlier this month Amazon Web Services introduced AWS for Health , an offering of curated AWS services and AWS Partner [...]
[Podcast] What Do COVID-19 and Birthdays Have in Common?
The first episode of Freakonomics, M.D. is now available. In this installment, Dr. Bapu Jena examines the impact of birthday [...]
UnitedHealthcare Faces Pandemic Criticism; Pediatricians Voice Discontent With Low COVID-19 Vaccine Reimbursement Rates
UnitedHealthcare is reportedly paying providers around half the normal rate for administering COVID-19 vaccines. The payer is also shortchanging pediatricians [...]
ISPOR Seeks Survey Respondents to Identify Key HEOR Trends
The Professional Society for Health Economics and Outcomes Research (ISPOR) has issued a survey to understand key trends in health [...]
Under Dems’ Drug Pricing Plan, Dozens of New Meds Will Never Be Invented
Under Dems’ Drug Pricing Plan, Dozens of New Meds Will Never Be Invented The Congressional Budget Office just released an [...]
Finland Healthcare, Regulatory and Reimbursement Landscape Market Report
Finland Healthcare, Regulatory and Reimbursement Landscape Market Report Finland Healthcare, Regulatory and Reimbursement Landscape Market Report is an essential source [...]
How pharma can help the post-COVID recovery of European cancer care
The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes [...]
With approval for China’s 2nd CAR-T therapy, Juno, WuXi joint venture goes up against Gilead and Fosun’s Yescarta
With approval for China's 2nd CAR-T therapy, Juno, WuXi joint venture goes up against Gilead and Fosun's Yescarta aliu Fri, [...]
Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines
Abstract Background Oncologists who author clinical practice guidelines frequently have financial relationships with the pharmaceutical industry. It is unknown whether [...]
House Democrats ramp up probe of FDA approval of Alzheimer’s drug – NewsBreak
Democratic leaders of two House committees are stepping up a probe of the Food and Drug Administration's (FDA) controversial approval [...]
New gene therapies may soon treat dozens of rare diseases, but price tags will put them out of reach for many – Japan Today
New gene therapies may soon treat dozens of rare diseases, but price tags will put them out of reach for [...]
Implementing More Effective FAIR Scientific Data Management With a Lakehouse
Data powers scientific discovery and innovation. But data is only as good as its data management strategy, the key factor [...]
HealthEconomics.Com Releases 2021 Insight Survey on Evidence-Based Healthcare
SAN DIEGO--(BUSINESS WIRE)--Sep 7, 2021-- HealthEconomics.Com , the world’s largest digital Connected Community™ for health economics and outcomes research (HEOR), [...]
Influential Usage of Big Data and Artificial Intelligence in Healthcare
Artificial intelligence (AI) is making computer systems capable of executing human brain tasks in many fields in all aspects of [...]